Newsbot

J.P.Morgan raises Jabils PT on strong AI demand, datacenter expansion

** J.P.Morgan lifts PT on electric components maker Jabil NYSE:JBL to $260 from $256, maintains rating at "overweight"** New PT shows an upside of 16.9% from the stocks last close** Brokerage says co poised for upside with strong AI server demand, balanced mix, and datacenter power expansion suppo…

GENESIS Pharma gibt neue Partnerschaft mit Otsuka Pharmaceutical Europe Ltd. zur Vermarktung von Donidalorsen für hereditäres Angioödem in Mittel- und Osteuropa bekannt

ATHEN, Griechenland--(BUSINESS WIRE)--  BEKANNTMACHUNG NUR FÜR EUROPÄISCHE MEDIZIN- UND PHARMAZEUTISCHE FACHMEDIEN SOWIE EUROPÄISCHE FINANZMEDIEN GENESIS Pharma, ein regionales Biopharmaunternehmen, das sich auf die Vermarktung innovativer Medikamente in Mittel- und Osteuropa konzentriert, gibt eine Exklusivvereinbarung mit Otsuka Pharmaceutical Europe Ltd. (OPEL), dem europäischen Zweig des globalen Gesundheitsunternehmens Otsuka Pharmaceutical Co., Ltd., für Donidalorsen bekannt. Gemäß den Ve

Aufschrei der Apotheker – jetzt startet dm seine Medikamenten-Offensive

Ab Dienstag kann man bei dm apothekenpflichtige Medikamente wie Aspirin oder Ibuprofen online bestellen. Mit dem Start seiner Online-Apotheke will die Drogeriemarktkette zum „Gesundheitsbegleiter“ seiner Kunden avancieren. Apothekerverbände warnen hingegen vor den Folgen.

JBL Stock Before Q1 Earnings: A Smart Buy or Risky Investment?

Jabil, Inc. JBL is scheduled to report first-quarter fiscal 2026 earnings on Dec. 17. The Zacks Consensus Estimate for sales and earnings is pegged at $8.01 billion and $2.7 per share, respectively. Earnings estimates for JBL have remained unchanged for 2025 and 2026 over the past 60 days.Earnings…

Statement from the independent bid committee of Irisity regarding the mandatory offer from Stockhorn Capital

The independent bid committee of Irisity AB (publ) (“Irisity” or the “Company”) unanimously recommends that Irisity’s shareholders do not accept the mandatory offer of SEK 0.132 per share (the “Offer”) made by Stockhorn Capital AB (“Stockhorn”) on 3 December 2025.BackgroundOn 6 November 2025, Stockhorn announced that Stockhorn had acquired 1,000 shares at a price of SEK 0.132 per share in Irisity, and that Stockhorn’s total holding after the acquisition amounted to 61,147,614 shares, corresp...

CDU für Wohnungs-Baugenehmigung nach drei Monaten

BERLIN (dpa-AFX) - Die CDU will den Bau von Wohnungen stärker ankurbeln und dafür Genehmigungen deutlich beschleunigen. Darauf zielt ein Leitantrag für den Bundesparteitag im Februar in Stuttgart, den der CDU-Bundesvorstand in Berlin beschloss. Es ge...

Beloved 80-year-old steakhouse closes for good, customers upset

You know that lovely restaurant in your town that has been around for as long as you can remember? Now, it’s time to say goodbye to it.  Running a business for 80 years is an achievement worthy of respect. It is far from true that 90% of restaurants fail within the first five years. Still, the ...

Are Investors Undervaluing Plains Group (PAGP) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy LATAM Airlines Group (LTM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Par Pacific (PARR) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy CNA Financial (CNA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Axos Financial (AX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Heres Why LATAM (LTM) is a Strong Value Stock

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Are Investors Undervaluing LaZBoy (LZB) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Patria Investments Limited (PAX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Daktronics (DAKT) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is LendingTree (TREE) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Amalgamated Financial (AMAL) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Magna International (MGA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.